PREdelivery Placental Biomarkers- Pregnancy and Delivery Outcome

NCT03100084 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2020-12-19

No results posted yet for this study

Summary

The PREPPeD study proposes that predelivery placenta-derived maternal circulating biomarkers reflect placental health, capacity and ageing, and can help predict onset and complications of delivery both in complicated pregnancies as well as in clinically uncomplicated term/post-term pregnancies.

Conditions

  • Pregnancy Complications
  • Placental Insufficiency

Interventions

OTHER

Blood sampling

Maternal blood sampling

Sponsors & Collaborators

  • Norwegian SIDS and Stillbirth Society

    collaborator OTHER
  • Extrastiftelsen

    collaborator OTHER
  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Meryam Sugulle, PhD, MD · Oslo University Hospital, Department of Obstetrics

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-15
Primary Completion
2022-09-01
Completion
2022-09-01

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03100084 on ClinicalTrials.gov